The drug combination was associated with significantly improved erectile function and partner satisfaction in men who did not respond to testosterone alone.
ED and neovascular age-related macular degeneration share some similar risk factors.
Avanafil has demonstrated a higher selectivity against the inhibition of phosphodiesterase 11.
Men with irritable bowel syndrome (IBS) are at higher risk of erectile dysfunction (ED) than men without IBS.
Aerobic exercise training could be a practical means of preventing ED brought on by a Western diet.
Researchers found the association in men presenting with suspected coronary artery disease.
The risk of ED is increased by about 75% if hypertension, diabetes, and hyperlipidemia are present concomitantly.
A trial conducted in 51 sites has found tadalafil (Cialis) once daily may help some men return to normal erectile function.
Infertility has dramatic effects on the emotional well-being of many individuals and couples.
Treatment approach studied in men who had an incomplete response to as-needed, maximum-dose phosphodiesterase type 5 inhibitors.
Likelihood of the condition increases 11% per year beginning at age 45.
Erectile dysfunction has predictive value for cardiovascular risk; tx may offer vascular benefits.
Long-term opiate use for back pain is associated with an increased risk of erectile dysfunction (ED).
Drs. Allen Seftel and Serge Carrier talk about whether or not urologists should screen for CVD and risk factors in patients with ED.
Men with erectile dysfunction (ED) have a higher prevalence of metabolic syndrome than those without ED.
A new study looking at the use of opioids suggests that long-term use may be associated with a significantly higher risk of ED.
Dose and duration of opioid use associated with increased odds of erectile dysfunction.
Under-treatment persists despite heavy promotion in the media.
Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer.
Tadalafil plus finasteride improved symptoms scores better than finasteride plus placebo.
Following surgery, symptom severity declined significantly and remained stable over 10 years.
Improvements in penile curvature deformity, Peyronie's disease bother score.
RLS increases the risk by 38%, data show.
In a study, CRP levels were significantly higher among ED sufferers who did not respond to tadalafil.
Herpes simplex virus infection is independently associated with a nearly threefold increased risk.
The drug, which is approved for treating men with erectile dysfunction, benign prostatic hyperplasia, or both conditions, also improved orgasmic function.
Men with erectile dysfunction (ED) are more likely to have chronic periodontitis than those without ED.
Adding testosterone therapy to sildenafil is not more effective in treating erectile dysfunction (ED) than sildenafil alone,
Significantly more 30- to 40-year-old males with erectile dysfunction have chronic periodontitis
Management of ED may improve adherence, treatment outcomes, decrease healthcare costs.